Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3
2008

IL-6 Prevents Hypovolemic Circulatory Collapse in Rats

Sample size: 25 publication 10 minutes Evidence: high

Author Information

Author(s): Jeffrey A. Alten, Ana Moran, Anna I. Tsimelzon, Mary-Ann A. Mastrangelo, Susan G. Hilsenbeck, Valeria Poli, David J. Tweardy

Primary Institution: Baylor College of Medicine

Hypothesis

Can IL-6 administration prevent hypovolemic circulatory collapse (HCC) and associated cardiac dysfunction in a rat model?

Conclusion

IL-6 administration at the start of resuscitation significantly prevents HCC, improves cardiac function, and reduces mortality in rats subjected to hemorrhagic shock.

Supporting Evidence

  • IL-6 treatment completely reversed HCC and prevented cardiac dysfunction.
  • Mortality was reduced nearly 5-fold in rats treated with IL-6 compared to placebo.
  • Cardiomyocyte apoptosis was significantly reduced in rats receiving IL-6.

Takeaway

When rats lose a lot of blood, they can get very sick. Giving them a special protein called IL-6 helps them recover and stay healthy.

Methodology

Rats were subjected to a hemorrhagic shock protocol and treated with IL-6 or placebo to assess the effects on cardiac function and apoptosis.

Limitations

The study was conducted in a rat model, which may not fully replicate human responses to hemorrhagic shock.

Participant Demographics

Adult male Sprague-Dawley rats were used in the study.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001605

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication